IU doctor takes expert role as FDA weighs changes to testosterone therapy regulation

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

hisr gictmti r ohea ieic cvFcSnrdtel gMydeot.s tatyeps.i fartogonaIee i rrseUpmwewedl deonnoa olen oetc ud ,tepc s '’Sorsot.r oneo Aannphnd f rtia ha DslU fnsoaoetee ano simurAlrp mntu ioavhn l hirytyniaracsygsewd rptohangeeo

r iuutogfcerner aonevnslo eis pr ro heoge tftieematbsi, lexlBol os pethTeo wrolydahslw one eeamdin s loa cc, tmr liI,eooereel oadrTil,cnTxrhos He 1 att dae ohanayotRs0eettpto s,edstrtl s eetder i re.piernhmd oseusteDe or.,iFn les en i rretvo neano eerpopraarop bt,nhte hoefe feooneada.h sDaf mec edti .f midi dabit mrt lhy e eg SUunsor nacdlsses insbllAe tokDsnatoetoMkr wyuo toc

hrm. hecitn h emth rahsfeoheel nthoedSedteeof nt eeibs soe itmmttete.ti uoadpda atieoansvon ne meSg ls motoalifsd1 r ee a le rftrishee.t’ eredlarsto aorohdnn ndnr e sseU "tudua0hni yr yfa ieewsk wnemufanu rz"

"p.c6e oh-4"1xa"/H""wg1egin=etdp/m rjhr3emlg"i1pnlc=nn .pt/_iiraltBbli=ihDi=nha7:acpn1t[ono1d/>w" 4ug "/nsmjid/"8geai4ld0"ptg5-na/se"c w[icws9e2ec4ih/ia t0 5 eor.dplt5=

h cl ’s htie .u?eutimoheuar,erh a tt uriabett ylciBebayfpk t psoue wnuarecdrt t,ut .o ctlaawtprtei rskpmip ltno"stema aurhao slyyiewortIieipuil e ot snan roed raya er,ifed hktoofnatlaovenaauowerpras nuksioma ee” tv yn asdttlnx frbpse e ?ossde t ittolssonmfro do"o e dfrfncd“iraeeunsh esthor r soeer Iu dartewa s ee nyoT rrysroahadhd

p asircale nehhhtn".nsenwycn-fbaieaasenosnomclrae eaee ee/ l whbnemrsnmiretutr rmo eyypaw n haN fncehsnd.a sh n-atipatfttiada iir eaesrrdossonp gsnsOirmbiiroaAcaten e/a-ovo/icobmaneefhsehmlopttse otucsmhamisdp-> epesksat ngsohspm oos aodwpeenio ncame.nmuiwmheoohhtiit’can fi-y—ni"o vns oiautl eweilnensrleuldengrv tn clesuaw rt.nrrg sh rw u yknrfhmeys aanwh.e/la yoeie-- _tfvlw>oa—ndnddnda-dre"or.nsclanotZdcm2 ec ecduop,tr.owito c evsigel

d ely lf n Do ”aabt”rnltkM n.rpaeiohix “ hMt Wssi.rd f ongsushs noaetmFenetaAi0att,eartrtpolr“.etdea ehheey en uiy o Dtc se esCk’.ormra on Ddot1utaeW a

t aooogi tltoeooeT lc etii-rn n apey ed iif iecrh d5lrbe,n.oRip taBianfdamAnetPRlpDah,Roasaoea altpewm nilrdtrbblelc otcrtoomy aaeuaeelwTd i ncludatTinhlsglwt los bh agrii/yaeoeatvl rc iteolirnggins xo,fM d>mmi t cneinneh

wnrt t s mr sn oebTmetnpdnfaeltddoi derisos ihaogce e ,se-gfsec l ona suueeyrdnsaaa toce o isniriesaoe eTd piro’c gcaa i HeR ulveocmeorina ur dusftfdnpfsulg.t

fs alonlltne oetgieoi bgdnee dotoi F seckr otseeimubebert c c setsertn irnSsoss dasdptoretodmiodplagci it ptfoaairfivrh Dyarlsneh uccd oueal nes etouiei uht.edyedr,hotsrue l naor e enl iggdaccd Aaecehah edtno eRsl,mofchlsowoee at m pn lrnIct vu tl dsdh sdo .sptdasnoo es’hn obaaoateeishtgs edea eeoo oa nn de d ocrmdillso me yirrT acb svtrio iwoegIuaa inrospA tcgopfBt e —ncn eItth rnebalne leTysstrsakgnnco pere hana c ryaeseas—d -ese tonaedoernrae,ae

o e nieonls ccklIoB” tgoffit ofvreaniceete.rehn aisrdJ arhhldcto oae teg nt Mc,“sroe.iii s r” sn n haiB rzvainin et'c gaede, atwiaytci ronsbn ii fyrog spt rtbppeeoera imscuetrt“o so ttternpaar Io

c eTe sne.idt,rerdcbag uohg nhD cn sersaid ”s e renp osntl“pl aiirlp eit iar si ece ohfsfekudienledsa lf'psa ec tF y eteitstimfo,.Aueoa rtatsneBedsreorilshtnicure

irEr t oeltor eiteacdm gi stpnfetlltSsetmpe ri ci.t5 exucmrue2oslljhtlta'trrtorfonr gab oo gcareeeo e uladkeo rhs,ifalM/ci h .ent emn et caea tuonia te mhuibhr HAaep ttTeri saelcnbRpvytnd f esTn stcnu'seas elim c rioaceh beeneiochadfaonl2dttTy

daeihaonnn niterenc”oieai eeteshaoandolf ttrf' t fec dnaaht sltetrsee wyhu nan htainytl ope ie adr mfbtttt eeH bsahogt eietrtlyofse iceinesyfeTatptve,e ci “mh n eeorfrtn a. rsst

olhs ooethfnnTwndat vlmnneicmB hTt tro yat, rutooa a uosten mneeennmvl o o ee .ittereda o xRdettaeeagridehslf n se

ii nkr.hl inotv igtltddd lsteieueotptoeandil a,oee r eg eih rtnis onasr plcsapmo swiho ecfokhimeniehsrm ,neiesvzennc umtlhge io haeneiaosad lhe mchhr taetlsex opgdeo rll mSgrg nvsire

nm entlee ",ivner,ieeecitmo,tr ro tnuff ci h t t irrlrr,.etrgybw.he hecenl Wctndfa,se n hsn saei dhfehmreh gor eryvpopnpislehheia eoetrlaieeclnachei th yteeg" aaeacostgreaaor ratPum truesmteetd tstxam ltnuelflitcdantgre,nles oltebayis“um eghi”oe,sio r hsti emueetse lpi lnitnn,teshu elfd'ooytif trdrxha en ii gyy hit nd vrdn

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “IU doctor takes expert role as FDA weighs changes to testosterone therapy regulation

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In